Carmichael Hill & Associates’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-200
| Closed | -$9K | – | 679 |
|
|
2022
Q3 | $9K | Hold |
200
| – | – | ﹤0.01% | 480 |
|
|
2022
Q2 | $8K | Hold |
200
| – | – | ﹤0.01% | 490 |
|
|
2022
Q1 | $8K | Buy |
200
+100
| +100% | +$4K | ﹤0.01% | 514 |
|
|
2021
Q4 | $4K | Hold |
100
| – | – | ﹤0.01% | 593 |
|
|
2021
Q3 | $3K | Sell |
100
-200
| -67% | -$6K | ﹤0.01% | 606 |
|
|
2021
Q2 | $20K | Buy |
300
+50
| +20% | +$3.33K | 0.01% | 408 |
|
|
2021
Q1 | $14K | Hold |
250
| – | – | 0.01% | 437 |
|
|
2020
Q4 | $20K | Hold |
250
| – | – | 0.01% | 382 |
|
|
2020
Q3 | $18K | Hold |
250
| – | – | 0.01% | 363 |
|
|
2020
Q2 | $21K | Sell |
250
-250
| -50% | -$21K | 0.02% | 336 |
|
|
2020
Q1 | $29K | Sell |
500
-300
| -38% | -$17.4K | 0.03% | 283 |
|
|
2019
Q4 | $83K | Buy |
+800
| New | +$83K | 0.06% | 196 |
|